Difference between revisions of "LncRNA-ATB"
(Created page with "==Annotation== ===Name=== lncRNA-ATB ===Alias=== NA ===Disease=== Disease: colorectal cancer [http://www.ncbi.nlm.nih.gov/pubmed/26487301 (PMID:26487301)] Dysfunction type:...") |
|||
| Line 1: | Line 1: | ||
| + | ''lncRNA-ATB'', a Long Noncoding RNA activated by TGF-β associated with poor prognosis in Hepatocellular Carcinoma (HCC) | ||
==Annotation== | ==Annotation== | ||
===Name=== | ===Name=== | ||
| − | lncRNA-ATB | + | ''lncRNA-ATB'', Long Noncoding RNA activated by TGF-β <ref name="ref1" /> |
===Alias=== | ===Alias=== | ||
NA | NA | ||
| − | === | + | ===Characteristics=== |
| − | + | ''lncRNA-ATB'' is a long noncoding RNA which is primarily activated by Transforming Growth Factor β (TGF-β) has been reported to be involved in specific physiological and pathological processes in human diseases, and could serve as biomarkers for cancers. ''lncRNA-ATB'' is poly (A)-negative and mainly located in the cytoplasm. ''lncRNA-ATB'' has no protein-coding potential since analysis of the sequences by ORF Finder from the National Center for Biotechnology Information failed to predict a protein of more than 55 amino acids. Moreover, ''lncRNA-ATB'' does not contain a valid Kozak sequence. <ref name="ref1" /> | |
| + | ===Function=== | ||
| + | ''lncRNA-ATB'' downregulates E-cadherin (E-cad) and induces epithelial-to- mesenchymal transition thereby promoting the invasion-metastasis in carcinoma. <ref name="ref2" /> | ||
| − | + | ''lncRNA-ATB'' also competitively binds the miR-200 family and then induces EMT and invasion by upregulating ZEB1 and ZEB2. lncRNA-ATB promotes EMT, HCC cell invasion, and metastatic organ colonization., lncRNA-ATB promotes organ colonization of disseminated tumor cells by binding IL-11 mRNA, autocrine induction of IL-11, and triggering STAT3 signaling. lncRNA-ATB, as a mediator of TGF-β signaling, could predispose HCC patients to metastases and may serve as a potential target for antimetastatic therapies. <ref name="ref1" /> | |
| − | + | ===Regulation=== | |
| + | ''lncRNA-ATB'' is regulated by Transforming Growth Factor β (TGF-β). Studies indicated that a short-term TGF-β treatment was sufficient to activate ''lncRNA-ATB'', which implied that ''lncRNA-ATB'' may be a direct target of TGF-β/Smad pathway, but how TGF-β activates ''lncRNA-ATB'' requires further investigation.<ref name="ref1" /> Long non-coding RNA-activated by TGF-β was upregulated in colon cancer tissues compared with adjacent mucosa. ''LncRNA-ATB'' levels were also higher in metastatic cancer tissues <ref name="ref2" /> | ||
| + | ===Expression=== | ||
| + | High level expression of ''lncRNA-ATB'' is associated with liver cirrhosis in patients with HCC and poor prognosis. High expression of ''lncRNA-ATB'' is a robust predictor of poor survival. ''LncRNA-ATB'' was activated by TGF-β and induced EMT not only in HCC cells, but also in colorectal cancer and breast cancer cells. <ref name="ref1" /> Striking differences were observed in overall survival and disease-free survival in cases with both high ''lncRNA-ATB'' expression and low E-cad expression. Reduction of ''lncRNA-ATB'' increased expression of epithelial markers E-cad, ZO-1, and decreased expression of mesenchymal markers ZEB1 and N-cadherin (N-cad), and significantly influenced colon cancer cell progression.<ref name="ref2" /> LncRNA-ATB expression is also commonly increased in Coal Workers’ Pneumoconiosis (CWP) and significantly correlates with the TGF-β1 in CWP patients. Furthermore, elevated ''lncRNA-ATB'' was associated with CWP risk and may serve as a potential biomarker for CWP.<ref name="ref3" /> | ||
| − | === | + | {| class='wikitable' style="text-align:center" |
| − | + | |- | |
| + | ! | Experiment | ||
| + | ! | Forward primer | ||
| + | ! | Reverse primer | ||
| + | |- | ||
| + | | rowspan="1"|qRT-PCR | ||
| + | | | 5'-CTTCACCAGCACCCAGAGA- 3' | ||
| + | | | 5'-AAGACAGAAAAACAGTTCCGAGTC- 3'<ref name="ref3" /> | ||
| + | |} | ||
| + | |||
| + | ===Diseases=== | ||
| + | *Breast cancer <ref name="ref1" /> | ||
| + | *Coal Workers’ Pneumoconiosis CWP <ref name="ref3" /> | ||
| + | *Colorectal cancer <ref name="ref2" /> | ||
| + | *Hepatocellular Carcinoma HCC <ref name="ref1" /> | ||
| − | + | ==Labs Working== | |
| + | *Department of Medical Genetics, Second Military Medical University, Shanghai, 200433, China | ||
| + | *The Third Department of Hepatic Surgery, Eastern Hepatobiliary Hospital, Second Military Medical University, Shanghai, 200433, China | ||
| + | *The Fifth Department of Hepatic Surgery, Eastern Hepatobiliary Hospital, Second Military Medical University, Shanghai, 200433, China | ||
| + | *Department of General Surgery, Shanghai Jiao Tong University Affiliated First People's Hospital, Shanghai, China | ||
| + | *Department of Occupational & Environmental Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China | ||
| + | *Key Laboratory of Environment and Health, Ministry of Education & Ministry of Environmental Protection, and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China | ||
| + | *Long Hua Center for Disease Control and Prevention, Shenzhen 518109, China | ||
| − | + | ==Reference== | |
| + | <references> | ||
| + | <ref name="ref1"> Yuan J-h, Yang F, Wang F, Ma J-z, Guo Y-j, Tao Q-f et al. A Long Noncoding RNA Activated by TGF-β Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma[J]. Cancer Cell. 2014, 25(5):666-681.</ref>(1) | ||
| + | <ref name="ref2"> Yue B, Qiu S, Zhao S, Liu C, Zhang D, Yu F et al. LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis[J]. Journal of Gastroenterology and Hepatology. 2016, 31(3):595-603.</ref>(2) | ||
| + | <ref name="ref3"> Ma J, Cui X, Rong Y, Zhou Y, Guo Y, Zhou M et al. Plasma LncRNA-ATB, a Potential Biomarker for Diagnosis of Patients with Coal Workers' Pneumoconiosis: A Case-Control Study[J]. International journal of molecular sciences. 2016, 17(8):1367.</ref>(3) | ||
| + | </references> | ||
Revision as of 04:57, 20 November 2018
lncRNA-ATB, a Long Noncoding RNA activated by TGF-β associated with poor prognosis in Hepatocellular Carcinoma (HCC)
Contents
Annotation
Name
lncRNA-ATB, Long Noncoding RNA activated by TGF-β [1]
Alias
NA
Characteristics
lncRNA-ATB is a long noncoding RNA which is primarily activated by Transforming Growth Factor β (TGF-β) has been reported to be involved in specific physiological and pathological processes in human diseases, and could serve as biomarkers for cancers. lncRNA-ATB is poly (A)-negative and mainly located in the cytoplasm. lncRNA-ATB has no protein-coding potential since analysis of the sequences by ORF Finder from the National Center for Biotechnology Information failed to predict a protein of more than 55 amino acids. Moreover, lncRNA-ATB does not contain a valid Kozak sequence. [1]
Function
lncRNA-ATB downregulates E-cadherin (E-cad) and induces epithelial-to- mesenchymal transition thereby promoting the invasion-metastasis in carcinoma. [2]
lncRNA-ATB also competitively binds the miR-200 family and then induces EMT and invasion by upregulating ZEB1 and ZEB2. lncRNA-ATB promotes EMT, HCC cell invasion, and metastatic organ colonization., lncRNA-ATB promotes organ colonization of disseminated tumor cells by binding IL-11 mRNA, autocrine induction of IL-11, and triggering STAT3 signaling. lncRNA-ATB, as a mediator of TGF-β signaling, could predispose HCC patients to metastases and may serve as a potential target for antimetastatic therapies. [1]
Regulation
lncRNA-ATB is regulated by Transforming Growth Factor β (TGF-β). Studies indicated that a short-term TGF-β treatment was sufficient to activate lncRNA-ATB, which implied that lncRNA-ATB may be a direct target of TGF-β/Smad pathway, but how TGF-β activates lncRNA-ATB requires further investigation.[1] Long non-coding RNA-activated by TGF-β was upregulated in colon cancer tissues compared with adjacent mucosa. LncRNA-ATB levels were also higher in metastatic cancer tissues [2]
Expression
High level expression of lncRNA-ATB is associated with liver cirrhosis in patients with HCC and poor prognosis. High expression of lncRNA-ATB is a robust predictor of poor survival. LncRNA-ATB was activated by TGF-β and induced EMT not only in HCC cells, but also in colorectal cancer and breast cancer cells. [1] Striking differences were observed in overall survival and disease-free survival in cases with both high lncRNA-ATB expression and low E-cad expression. Reduction of lncRNA-ATB increased expression of epithelial markers E-cad, ZO-1, and decreased expression of mesenchymal markers ZEB1 and N-cadherin (N-cad), and significantly influenced colon cancer cell progression.[2] LncRNA-ATB expression is also commonly increased in Coal Workers’ Pneumoconiosis (CWP) and significantly correlates with the TGF-β1 in CWP patients. Furthermore, elevated lncRNA-ATB was associated with CWP risk and may serve as a potential biomarker for CWP.[3]
| Experiment | Forward primer | Reverse primer |
|---|---|---|
| qRT-PCR | 5'-CTTCACCAGCACCCAGAGA- 3' | 5'-AAGACAGAAAAACAGTTCCGAGTC- 3'[3] |
Diseases
- Breast cancer [1]
- Coal Workers’ Pneumoconiosis CWP [3]
- Colorectal cancer [2]
- Hepatocellular Carcinoma HCC [1]
Labs Working
- Department of Medical Genetics, Second Military Medical University, Shanghai, 200433, China
- The Third Department of Hepatic Surgery, Eastern Hepatobiliary Hospital, Second Military Medical University, Shanghai, 200433, China
- The Fifth Department of Hepatic Surgery, Eastern Hepatobiliary Hospital, Second Military Medical University, Shanghai, 200433, China
- Department of General Surgery, Shanghai Jiao Tong University Affiliated First People's Hospital, Shanghai, China
- Department of Occupational & Environmental Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
- Key Laboratory of Environment and Health, Ministry of Education & Ministry of Environmental Protection, and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
- Long Hua Center for Disease Control and Prevention, Shenzhen 518109, China
Reference
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 Yuan J-h, Yang F, Wang F, Ma J-z, Guo Y-j, Tao Q-f et al. A Long Noncoding RNA Activated by TGF-β Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma[J]. Cancer Cell. 2014, 25(5):666-681.
- ↑ 2.0 2.1 2.2 2.3 Yue B, Qiu S, Zhao S, Liu C, Zhang D, Yu F et al. LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis[J]. Journal of Gastroenterology and Hepatology. 2016, 31(3):595-603.
- ↑ 3.0 3.1 3.2 Ma J, Cui X, Rong Y, Zhou Y, Guo Y, Zhou M et al. Plasma LncRNA-ATB, a Potential Biomarker for Diagnosis of Patients with Coal Workers' Pneumoconiosis: A Case-Control Study[J]. International journal of molecular sciences. 2016, 17(8):1367.
